Published online before print May 8, 2008

This Article Full Text (Rapid PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Adhami, F. Articles by Kuan, C.-Y. PubMed PubMed Citation Articles by Adhami, F. Articles by Kuan, C.-Y.

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.070979

Accepted for publication March 13, 2008.

Article

Deleterious Effects of Plasminogen Activators in Neonatal Cerebral Hypoxia-Ischemia

Faisal Adhami^*, Dan Yu^*, Wei Yin, Aryn Schloemer^*, Kevin A. Burns^*, Guanghong Liao^*, Jay L. Degen^*, Jun Chen, and Chia-Yi Kuan^*@

From the Division of Developmental Biology and Neurology,* Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; the Physician Scientist Training Program, University of Cincinnati, College of Medicine, Cincinnati, Ohio; the Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

^@ To whom correspondence should be addressed. E-mail: alex.kuan{at}cchmc.org.

	Abstract

The immature brains of newborns often respond differently from the brains of adults when exposed to similar insults. Previous studies have indicated that although hypoxia-ischemia (HI) induces persistent thrombosis in adult brains, it only modestly impairs blood perfusion in newborn brains. Here, we used the Vannucci model of HI encephalopathy to study age-related responses to cerebral HI in rat pups. We found that HI triggered fibrin deposition and impaired blood perfusion in both neonatal and adult brains. However, these effects were only transient in neonatal brains (<4 hours) and were accompanied by acute induction of both tissue-type and urinary-type plasminogen activators (tPA and uPA), which was not observed in adult brains subjected to the same insult. Interestingly, activation of the plasminogen system persisted up to 24 hours in neonatal brains, long after the clearance of fibrin-rich thrombi. Furthermore, astrocytes and macrophages outside blood vessels expressed tPA after HI, suggesting the possibility of tPA/plasmin-mediated cytotoxicity. Consistent with this hypothesis, injection of 2-antiplasmin into cerebral ventricles markedly ameliorated HI-induced damage to neurofilaments and white matter oligodendrocytes, providing a dose-response reduction of brain injury after 7 days of recovery. Conversely, ventricular injection of tPA increased HI-induced brain damage. Together, these results suggest that tPA/plasmin induction, which may contribute to acute fibrinolysis, is a critical component of extravascular proteolytic damage in immature brains, representing a new therapeutic target for the treatment of HI encephalopathy.